US 12036280
High concentration protein formulation
granted A61KA61K38/00A61K39/39591
Quick answer
US patent 12036280 (High concentration protein formulation) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/00, A61K39/39591, A61K47/10, A61K47/14